CV and mad panic behaviour

[LP]

Novavax has been adopted by Indonesia and that will be a very decent trial sample.....

Sputnik, Sinovax, CoronaVac, Covaxin, AZ, Pfizer, Moderna, J&J and others have already issued about 3.2 Billion doses. I doubt any of them have much to fear, because it's highly unlikely Novavax exits any large scale roll out unscathed.

I'm quite cynical because the Novavax push appears to me to be more profit orientated than science based.

For reference, because they are selling vaccines for profit Novavax, Pfizer and Moderna are about 400% more expensive on average to the end user than AZ, Sinovax, Sputnik, Covaxin, etc., etc...

From a manufacturing perspective, it might be harder to make a mRNA hybrid (Influenza / Sars-CoV-2) vaccine, than it will be to formulate the same in viral vector(AZ) or protein sub-units(Novavax). I suspect in terms of Sars-CoV-2 it would be the mRNA vaccines that might lose out longer term.

PS: About 90% of vaccinations in Indonesia to date are Sinovax / CoronaVac, Indonesia they are not a big player in mRNA or Viral Vector. I wonder if the Indonesia Novavax push part of getting in on Australia's obligation under Covax to donate millions of doses of vaccine, whatever that vaccine may be? It feels like the sort of deal Scomo might do for some nuclear sub support in return!